xi’an salus nutra inc established in 2015 and located in hi-tech industrial zone in xi’an city, which is the most advanced area in northwest china . salus nutra is a professional company specialized in natural plant extracts, collagen and high technology chemical api field in scientific research, producing and marketing.
our products are mainly used in healthcare supplement, chemicals ,pharmaceutical, cosmetics and food additives. we are also engaged in supplying customization oem service to help customers choose their right ingredients and develop their broad markets .
our factory is located in baoji ,shaanxi province, it coveries an area of xx acres and equips with 2 standard production workshops meet with state health standards ,meanwhile employs more than 500 people with well-educated, including undergraduate, postgraduate and some technical persons with rich experience.
salus is committed to supplying safe, pure and healthy products that meet the high expectations of our customers. experienced and dedicated members of the quality and food safety department work to provide in-depth analyses, testing and monitoring of our products, during and after the manufacturing processes and ensure the quality and safety according to the highest standards.
we are based on the honest and mutual benefits, rely on the reliable quality and best after-sale service to make good reputations both online and offline. now it shares a great popularities from the customers at overseas. our primary goal aims to solve customer problems through research & development & technical service .
if you have any doubts or confusion, yes, salus will present the exactly right answer.
name: breviscapine
specification:98%
extract part: flower
test method: hplc
extractmolecular formula: c21h18o12
molecular weight: 462.4
erigeron beviscapus extract breviscapine belongs to erigeron reviscapus flavonsides extracted. pharmacology dilating brain blood vessels, reducing obstruction of brain vessels, increasing blood flow in brain, improving microcirculation, and showing antiplat elet aggregation. according to the above functions, we have researched and manufactured brevicapine tablet. it can treat paralysis resulting from cerebral vascular vascular occlusion and brain bleeding. indications application to apoplexy, angina pectoris and coronary heart disease.
1.it can prevent osteoporosis effectively.
2.prevention and treatment of prostate cancer.
3.daidzein can reduce the dependence on alcohol.
4.can enhance the efficacy of tamoxifen in the treatment of breast cancer.
5. inhibit the growth of leukemic cells and melanoma cells.
6.prevention of alzheimer's disease, prevention of cardiovascular disease, prevention of breast cancer.
7.can increase the secretion of gonads, thereby improving the quality of sexual life.
1.application in the nutraceuticals food, it has become a new raw material which used in food and nutraceuticals industry;
2.application in the health product field;
3.application in the pharmaceutical field;
4.application in the dietary supplement and cosmetics industries;
breviscapine |
|||||
name: |
breviscapine |
origin: |
p. r. china |
||
packing: |
25kg/drum |
type of extraction: |
ethanol |
||
item |
specification |
method |
|||
basic product information |
|||||
product name |
breviscapine |
/ |
|||
country of origin |
china |
/ |
|||
organoleptic data |
|||||
appearance |
white powder |
gb/t 5492-2008 |
|||
odor& taste |
characteristic |
gb/t 5492-2008 |
|||
process data |
|||||
solvent(s) used |
water and ethyl alcohol |
/ |
|||
breviscapine |
98% |
hplc |
|||
physical characteristics |
|||||
particle size |
98.0%pass 80mesh |
gb/t 5507-2008 |
|||
moisture |
<1.0% |
gb/t 14769-1993 |
|||
ash content |
<1.0% |
aoac 942.05, 18th |
|||
solvent residue |
eur. pharm |
nls-qcs-1007 |
|||
heavy metals |
|||||
total heavy metals |
<10 ppm |
usp <231>, method ii |
|||
arsenic |
<1.0 ppm |
aoac 986.15, 18th |
|||
lead |
<1.0 ppm |
aoac 986.15, 18th |
|||
mercury |
<0.5 ppm |
aoac 971.21, 18th |
|||
pesticide residue |
|||||
666 |
<0.2ppm |
gb/t5009.19-1996 |
|||
ddt |
<0.2ppm |
gb/t5009.19-1996 |
|||
microbiology |
|||||
total plate count |
<1,000cfu/g |
aoac 990.12, 18th |
|||
total yeast & mold |
<100cfu/g |
fda (bam) chapter 18, 8th ed. |
|||
e. coli |
negative |
aoac 997.11, 18th |
|||
salmonella |
negative |
fda (bam) chapter 5, 8th ed. |